Document Detail


Estrogen replacement therapy for depression in perimenopausal women.
MedLine Citation:
PMID:  19810294     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
OBJECTIVE: To determine the effect of a four-week course of oral estrogen therapy on depression in aging women. DESIGN: Quasi experimental. PLACE AND DURATION OF STUDY: The OPD, Bahawal Victoria Hospital, Bahawalpur, from September 2000 to January 2004. PATIENTS AND METHODS: Forty-two depressed women (aged 42-57) who were either perimenopausal (n = 20) or postmenopausal (n = 22) received open label treatment with oral estrogen tablets (1.25 mg/day) for 4 weeks. The Montgomery-Asberg Depression Rating Scale and the Beck Depression Inventory were used to assess depressive symptoms, the Greene Climacteric Scale was used to assess menopause-related symptoms, and the Clinical Global Impression(CGI) was used to assess global clinical improvement in these women at baseline and after treatment. Remission of depression was defined as a score < 10 on the Montgomery-Asberg Depression Rating Scale and a score < or = 2 on the CGI at week 4. RESULTS: The women who completed the study had a median Montgomery-Asberg Depression Rating Scale score of 20 (range = 15-32) at study entry and 11.50 (range = 10-31.0) at week 4 (z = -3.43, p < 0.01). This improvement was consistent with that reported by the women themselves on the Beck Depression Inventory (rs = 0.86, n = 20, p < 0.01). The improvement measured by CGI scores was also significant (p < 0.01). Remission of depression was noted in 5 of the 40 women (after 1 year) who completed the study. Anti-depressant response was not associated with severity or subtypes of depression at study entry or with concomitant improvement in menopause-related symptoms. CONCLUSION: Perimenopausal and postmenopausal women benefit from short-term use of estrogen therapy. Antidepressant effect of estrogen therapy is independent of improvement in menopause-related symptoms.
Authors:
Asma Shaukat; Tariq Mahmud Arain; Amna Shahid; Shahid Irfan; Soufia Farrukh
Related Documents :
1486774 - Use of a monophasic, low-dose oral contraceptive in relation to mental functioning.
16020404 - The effects of remifemin on subjective symptoms of menopause.
23438654 - Safety in pharmacological enhancement of stroke rehabilitation.
21349204 - A randomised, feasibility trial of a tele-health intervention for acute coronary syndro...
1486774 - Use of a monophasic, low-dose oral contraceptive in relation to mental functioning.
16437504 - Antifungal agents for preventing fungal infections in non-neutropenic critically ill pa...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Journal of the College of Physicians and Surgeons--Pakistan : JCPSP     Volume:  15     ISSN:  1022-386X     ISO Abbreviation:  J Coll Physicians Surg Pak     Publication Date:  2005 Oct 
Date Detail:
Created Date:  2009-10-08     Completed Date:  2009-11-10     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9606447     Medline TA:  J Coll Physicians Surg Pak     Country:  Pakistan    
Other Details:
Languages:  eng     Pagination:  597-600     Citation Subset:  IM    
Affiliation:
Department of Pathology, Quaid-i-Azam Medical College, Bahawalpur.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adult
Depression / drug therapy*
Estrogen Replacement Therapy*
Female
Humans
Middle Aged
Perimenopause
Treatment Outcome

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  The outcome of subtotal abdominal hysterectomy.
Next Document:  Comparison of unfractionated heparin vs low molecular weight heparin in the treatment of acute deep ...